We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+24.71%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$866M
AUM Growth
+$149M
Cap. Flow
+$43.9M
Cap. Flow %
5.07%
Top 10 Hldgs %
7.14%
Holding
453
New
147
Increased
91
Reduced
74
Closed
130

Sector Composition

Rank Sector Weight
1 Healthcare 23.59%
2 Technology 18.66%
3 Consumer Discretionary 13.65%
4 Industrials 11.89%
5 Communication Services 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAAS
26
DELISTED
inContact, Inc.
SAAS
$4.74M 0.55%
+434,806
New +$4.38M
GTT
27
DELISTED
GTT Communications, Inc.
GTT
$4.7M 0.54%
249,054
+1,712
+0.7% +$24.9K
KONA
28
DELISTED
Kona Grill, Inc.
KONA
$4.61M 0.53%
162,116
+1,113
+0.7% +$27.6K
GTN icon
29
Gray Television
GTN
$415M
$4.58M 0.53%
+331,013
New +$3.76M
INN
30
Summit Hotel Properties
INN
$746M
$4.57M 0.53%
+324,665
New +$4.32M
TTPH
31
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$4.56M 0.53%
6,226
-2,286
-27% -$1.72M
NVAX icon
32
Novavax
NVAX
$1.2B
$4.49M 0.52%
27,164
-7,720
-22% -$1.25M
BFX
33
DELISTED
BowFlex Inc.
BFX
$4.47M 0.52%
292,782
-9,515
-3% -$144K
CEMP
34
DELISTED
Cempra, Inc.
CEMP
$4.47M 0.52%
130,265
-101,021
-44% -$3.04M
IPHI
35
DELISTED
INPHI CORPORATION
IPHI
$4.46M 0.52%
250,398
+100,693
+67% +$1.89M
MACK
36
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4.42M 0.51%
47,283
-5,112
-10% -$435K
ZLTQ
37
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$4.41M 0.51%
142,891
-623
-0.4% -$19.9K
PDCE
38
DELISTED
PDC Energy, Inc.
PDCE
$4.39M 0.51%
+81,298
New +$3.94M
FRSH
39
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$4.22M 0.49%
232,838
+74,638
+47% +$1.02M
COLM icon
40
Columbia Sportswear
COLM
$3.04B
$4.21M 0.49%
69,190
+13,464
+24% +$681K
DVAX
41
DELISTED
Dynavax Technologies
DVAX
$4.21M 0.49%
+187,679
New +$3.6M
SSP icon
42
E.W. Scripps
SSP
$257M
$4.1M 0.47%
+162,315
New +$3.26M
FORM icon
43
FormFactor
FORM
$8.28B
$4.09M 0.47%
461,661
+34,688
+8% +$301K
TBHC
44
DELISTED
The Brand House Collective
TBHC
$4.06M 0.47%
170,920
+10,893
+7% +$261K
GIII icon
45
G-III Apparel Group
GIII
$1.54B
$4.04M 0.47%
71,730
+13,900
+24% +$716K
AMAG
46
DELISTED
AMAG Pharmaceuticals
AMAG
$4.03M 0.47%
73,713
-22,845
-24% -$1.09M
MGNX icon
47
MacroGenics
MGNX
$235M
$4.02M 0.46%
128,176
+13,137
+11% +$445K
DYAX
48
DELISTED
DYAX CORPORATION
DYAX
$4.01M 0.46%
239,378
+46,572
+24% +$725K
AYI icon
49
Acuity Brands
AYI
$9.83B
$3.99M 0.46%
23,704
+4,611
+24% +$723K
ABMD
50
DELISTED
Abiomed Inc
ABMD
$3.98M 0.46%
55,577
-17,943
-24% -$974K

Similar funds

EAM Investors's Q1 2015 Portfolio in Review

As of Q1 2015, EAM Investors held 453 positions worth $866M, up 21% from $717M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

EAM Investors deployed $43.9M of net new capital in Q1 2015, opening 147 new positions and adding to 91 existing holdings. Its largest new stake was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Esperion Therapeutics, an estimated $6.11M trimmed.

  • EAM Investors's largest Q1 2015 buy was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
  • EAM Investors added most to NEVRO CORP. in Q1 2015, an estimated $3.15M increase.
  • EAM Investors's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $6.11M.
  • EAM Investors fully exited Imperva, Inc. in Q1 2015, selling an estimated $5.46M.
  • EAM Investors's ten largest holdings make up 7.1% of its $866M portfolio in Q1 2015.
  • EAM Investors opened 147 new positions and closed 130 in Q1 2015.
  • EAM Investors's portfolio value rose 21% quarter-over-quarter to $866M.

Based on EAM Investors's 13F filing for Q1 2015, filed 7 May 2015.